Successful non-myeloablative allogeneic transplantation for treatment of idiopathic hypereosinophilic syndrome. 2002

Naoto T Ueno, and Athanasios Anagnostopoulos, and Gabriela Rondón, and Richard E Champlin, and N Mikhailova, and O S Pankratova, and L S Zoubarovskaya, and E V Semenova, and B V Afanasyev, and Susan O'Brien, and Michael Andreeff, and Andrey Y Zaritskey
Department of Blood and Marrow Transplantation, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. nueno@mdanderson.org

In this report, we describe two patients with idiopathic hypereosinophilic syndrome (HES) who received a non-myeloablative allogeneic transplantation following a reduced-intensity preparative regimen of melphalan and fludarabine. In both cases, complete donor chimaerism and remission were achieved, and have lasted for more than 10 months. This report provides proof of principle for the feasibility of non-myeloablative transplantation for patients with idiopathic HES, who can show co-morbidity due to eosinophilic infiltration of their organs.

UI MeSH Term Description Entries
D008297 Male Males
D008558 Melphalan An alkylating nitrogen mustard that is used as an antineoplastic in the form of the levo isomer - MELPHALAN, the racemic mixture - MERPHALAN, and the dextro isomer - MEDPHALAN; toxic to bone marrow, but little vesicant action; potential carcinogen. Medphalan,Merphalan,Phenylalanine Mustard,Sarcolysine,Sarkolysin,4-(Bis(2-chloroethyl)amino)phenylalanine,Alkeran,L-PAM,Mustard, Phenylalanine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy
D014184 Transplantation, Homologous Transplantation between individuals of the same species. Usually refers to genetically disparate individuals in contradistinction to isogeneic transplantation for genetically identical individuals. Transplantation, Allogeneic,Allogeneic Grafting,Allogeneic Transplantation,Allografting,Homografting,Homologous Transplantation,Grafting, Allogeneic
D014740 Vidarabine A nucleoside antibiotic isolated from Streptomyces antibioticus. It has some antineoplastic properties and has broad spectrum activity against DNA viruses in cell cultures and significant antiviral activity against infections caused by a variety of viruses such as the herpes viruses, the VACCINIA VIRUS and varicella zoster virus. Adenine Arabinoside,Ara-A,Arabinofuranosyladenine,Arabinosyladenine,9-beta-Arabinofuranosyladenine,9-beta-D-Arabinofuranosyladenine,Ara A,Vira-A,alpha-Ara A,alpha-D-Arabinofuranosyladenine,beta-Ara A,9 beta Arabinofuranosyladenine,9 beta D Arabinofuranosyladenine,Arabinoside, Adenine,Vira A,ViraA,alpha Ara A,alpha D Arabinofuranosyladenine,beta Ara A
D016026 Bone Marrow Transplantation The transference of BONE MARROW from one human or animal to another for a variety of purposes including HEMATOPOIETIC STEM CELL TRANSPLANTATION or MESENCHYMAL STEM CELL TRANSPLANTATION. Bone Marrow Cell Transplantation,Grafting, Bone Marrow,Transplantation, Bone Marrow,Transplantation, Bone Marrow Cell,Bone Marrow Grafting
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes
D017681 Hypereosinophilic Syndrome A heterogeneous group of disorders with the common feature of prolonged eosinophilia of unknown cause and associated organ system dysfunction, including the heart, central nervous system, kidneys, lungs, gastrointestinal tract, and skin. There is a massive increase in the number of EOSINOPHILS in the blood, mimicking leukemia, and extensive eosinophilic infiltration of the various organs. Endocarditis, Loeffler's,Idiopathic Hypereosinophilic Syndrome,Leukemia, Eosinophilic,Loeffler's Endocarditis,Endocarditis, Loeffler,Hypereosinophilic Syndrome, Idiopathic,Loeffler Endocarditis,Endocarditis, Loefflers,Eosinophilic Leukemia,Eosinophilic Leukemias,Hypereosinophilic Syndromes,Hypereosinophilic Syndromes, Idiopathic,Idiopathic Hypereosinophilic Syndromes,Leukemias, Eosinophilic,Loefflers Endocarditis,Syndrome, Hypereosinophilic,Syndrome, Idiopathic Hypereosinophilic,Syndromes, Hypereosinophilic,Syndromes, Idiopathic Hypereosinophilic

Related Publications

Naoto T Ueno, and Athanasios Anagnostopoulos, and Gabriela Rondón, and Richard E Champlin, and N Mikhailova, and O S Pankratova, and L S Zoubarovskaya, and E V Semenova, and B V Afanasyev, and Susan O'Brien, and Michael Andreeff, and Andrey Y Zaritskey
March 2002, Bone marrow transplantation,
Naoto T Ueno, and Athanasios Anagnostopoulos, and Gabriela Rondón, and Richard E Champlin, and N Mikhailova, and O S Pankratova, and L S Zoubarovskaya, and E V Semenova, and B V Afanasyev, and Susan O'Brien, and Michael Andreeff, and Andrey Y Zaritskey
April 1995, Bone marrow transplantation,
Naoto T Ueno, and Athanasios Anagnostopoulos, and Gabriela Rondón, and Richard E Champlin, and N Mikhailova, and O S Pankratova, and L S Zoubarovskaya, and E V Semenova, and B V Afanasyev, and Susan O'Brien, and Michael Andreeff, and Andrey Y Zaritskey
May 1995, British journal of haematology,
Naoto T Ueno, and Athanasios Anagnostopoulos, and Gabriela Rondón, and Richard E Champlin, and N Mikhailova, and O S Pankratova, and L S Zoubarovskaya, and E V Semenova, and B V Afanasyev, and Susan O'Brien, and Michael Andreeff, and Andrey Y Zaritskey
April 2004, Haematologica,
Naoto T Ueno, and Athanasios Anagnostopoulos, and Gabriela Rondón, and Richard E Champlin, and N Mikhailova, and O S Pankratova, and L S Zoubarovskaya, and E V Semenova, and B V Afanasyev, and Susan O'Brien, and Michael Andreeff, and Andrey Y Zaritskey
January 2009, American journal of therapeutics,
Naoto T Ueno, and Athanasios Anagnostopoulos, and Gabriela Rondón, and Richard E Champlin, and N Mikhailova, and O S Pankratova, and L S Zoubarovskaya, and E V Semenova, and B V Afanasyev, and Susan O'Brien, and Michael Andreeff, and Andrey Y Zaritskey
March 2007, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
Naoto T Ueno, and Athanasios Anagnostopoulos, and Gabriela Rondón, and Richard E Champlin, and N Mikhailova, and O S Pankratova, and L S Zoubarovskaya, and E V Semenova, and B V Afanasyev, and Susan O'Brien, and Michael Andreeff, and Andrey Y Zaritskey
April 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
Naoto T Ueno, and Athanasios Anagnostopoulos, and Gabriela Rondón, and Richard E Champlin, and N Mikhailova, and O S Pankratova, and L S Zoubarovskaya, and E V Semenova, and B V Afanasyev, and Susan O'Brien, and Michael Andreeff, and Andrey Y Zaritskey
May 2009, Seminars in oncology nursing,
Naoto T Ueno, and Athanasios Anagnostopoulos, and Gabriela Rondón, and Richard E Champlin, and N Mikhailova, and O S Pankratova, and L S Zoubarovskaya, and E V Semenova, and B V Afanasyev, and Susan O'Brien, and Michael Andreeff, and Andrey Y Zaritskey
December 2001, Best practice & research. Clinical haematology,
Naoto T Ueno, and Athanasios Anagnostopoulos, and Gabriela Rondón, and Richard E Champlin, and N Mikhailova, and O S Pankratova, and L S Zoubarovskaya, and E V Semenova, and B V Afanasyev, and Susan O'Brien, and Michael Andreeff, and Andrey Y Zaritskey
July 2006, Leukemia & lymphoma,
Copied contents to your clipboard!